TET2 and chronic myelomonocytic leukemia: Patients with MDS who have more than one TET2 mutation have significantly increased monocyte counts in the bone marrow and peripheral blood, more specifically TET2I1873T mutation has been found to be significantly associated with progression to chronic myelomonocytic leukemia (CMML) [43].